A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC)
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7113-7113
◽
Keyword(s):
Phase I
◽